Yuan Xu
Insider Reports History
- Location
- South San Francisco, CA
- Signature
- /s/ Jonathan Young, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Yuan Xu:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| FATE THERAPEUTICS INC | Director | Stock Option (Right to Buy) | 55,000 | $109,200 | $2.73 | 29 May 2025 | Direct |
| FATE THERAPEUTICS INC | Director | Common Stock | 8,669 | $36,670 | $4.23 | 06 Aug 2024 | Direct |
| Akero Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $54.09 | 09 Dec 2025 | Direct |
| Xilio Therapeutics, Inc. | Director | Stock Option (right to buy) | 31,000 | 11 Jun 2025 | Direct | ||
| Akero Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 09 Dec 2025 | Direct |
Insider Reports Filed by Yuan Xu
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | 09 Dec 2025 | 6 | $0 | 4 | Director | 09 Dec 2025, 10:25 |
| XLO | Xilio Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 12 Jun 2025, 16:35 |
| AKRO | Akero Therapeutics, Inc. | 03 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 16:05 |
| FATE | FATE THERAPEUTICS INC | 29 May 2025 | 1 | $0 | 4 | Director | 30 May 2025, 16:09 |
| FATE | FATE THERAPEUTICS INC | 06 Aug 2024 | 1 | -$2,678 | 4 | Director | 07 Aug 2024, 16:01 |
| XLO | Xilio Therapeutics, Inc. | 14 Jun 2024 | 1 | $0 | 4 | Director | 17 Jun 2024, 16:30 |
| AKRO | Akero Therapeutics, Inc. | 08 Jun 2024 | 1 | $0 | 4 | Director | 11 Jun 2024, 17:31 |
| FATE | FATE THERAPEUTICS INC | 07 Jun 2024 | 1 | $0 | 4 | Director | 11 Jun 2024, 16:28 |
| FATE | FATE THERAPEUTICS INC | 04 Aug 2023 | 1 | -$2,345 | 4 | Director | 07 Aug 2023, 16:01 |
| AKRO | Akero Therapeutics, Inc. | 23 Jun 2023 | 1 | $0 | 4 | Director | 27 Jun 2023, 18:00 |
| FATE | FATE THERAPEUTICS INC | 14 Jun 2023 | 1 | -$19,307 | 4 | Director | 15 Jun 2023, 16:05 |
| XLO | Xilio Therapeutics, Inc. | 12 Jun 2023 | 1 | $0 | 4 | Director | 13 Jun 2023, 16:30 |
| FATE | FATE THERAPEUTICS INC | 06 Jun 2023 | 1 | $0 | 4 | Director | 07 Jun 2023, 16:15 |
| XLO | Xilio Therapeutics, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:30 |
| FATE | FATE THERAPEUTICS INC | 09 Jun 2022 | 2 | $0 | 4 | Director | 13 Jun 2022, 16:44 |
| AKRO | Akero Therapeutics, Inc. | 02 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 16:06 |
| XLO | Xilio Therapeutics, Inc. | 04 Jan 2022 | 1 | $0 | 4 | Director | 06 Jan 2022, 17:48 |
| XLO | Xilio Therapeutics, Inc. | 04 Jan 2022 | 0 | $0 | 3 | Director | 06 Jan 2022, 17:40 |
| FATE | FATE THERAPEUTICS INC | 03 Aug 2021 | 2 | $0 | 4 | Director | 05 Aug 2021, 16:04 |
| FATE | FATE THERAPEUTICS INC | 03 Aug 2021 | 0 | $0 | 3 | Director | 05 Aug 2021, 16:01 |
| AKRO | Akero Therapeutics, Inc. | 01 Jun 2021 | 1 | $0 | 4 | Director | 03 Jun 2021, 17:57 |